Trials / Unknown
UnknownNCT02987361
Effect of tDCS on Upper Extremity After Strokes
Effects of Transcranial Direct Current Stimulation on Hemiplegic Upper Extremity Function After Strokes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve upper limb motor recovery in the sub-acute phase of stroke patients. This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial.
Detailed description
The investigators hypothesize that transcranial direct current stimulation (tDCS) can improve upper limb motor recovery in the sub-acute phase of stroke patients. This is a randomized, controlled, double blind, cross-over, multicentre, clinical trial. Informed consent was obtained from all participants and procedures were conducted according to the Declaration of Helsinki. The protocol was approved by the Chonbuk National Uni. Hospital IRB, KOREA. Seventy-two stroke patients in the sub-acute phase will be recruited in three centers of neurorehabilitation in republic of Korea. Patients will be randomly divided to four groups; group1 is anodal stimulation on the lesioned primary motor cortex, group 2 is cathodal stimulation on the non-lesioned primary motor cortex, group 3 is dual stimulation such as anodal stimulation on the lesioned side and cathod stimulation on the non-lesioned side, and group 4 is shame stimulation group. The stimulation will be conducted 2mA for 20 minute a day, 5 days per weeks, totally 2 weeks. Fugl-Meyer upper motor score will be measured as a primary outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DC-STIMULATOR PLUS | 2mA for 20minutes a day, 5 days per weeks, totally 2 weeks |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2016-12-01
- Completion
- 2018-08-01
- First posted
- 2016-12-08
- Last updated
- 2016-12-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02987361. Inclusion in this directory is not an endorsement.